The alliance will leverage Ascentage Pharma’s expertise in structure-based little molecule design, lead optimization and preclinical advancement with 3SBio’s confirmed drug development and commercialization features in China. Related StoriesFDA grants accelerated acceptance for Tagrisso to take care of patients with advanced NSCLCNew antenna-like device makes breast cancer surgery less difficult for surgeonsCrucial change in single DNA bottom predisposes children to aggressive form of cancer Beneath the conditions of the agreement, 3SBio can make a US$3 million equity purchase in Ascentage Pharma.Ladapo, NYU College of MedicineUsing integrated molecular pathology to manage incidental pancreatic cysts: an interview with Dr Ananya DasAddressing quality of life needs in prostate cancer: an interview with Professor Louis Denis As president of Loyola's chapter of the Latino Medical Pupil Association , Mendez helped reinstate the chapter that has now turn into a vibrant portion of the medical school culture.